USANA Health Sciences, Inc.
USNA
$23.83
$0.090.38%
NYSE
| 12/28/2024 | 09/28/2024 | 06/29/2024 | 03/30/2024 | 12/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 854.50M | 861.97M | 875.12M | 900.45M | 921.01M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 854.50M | 861.97M | 875.12M | 900.45M | 921.01M |
| Cost of Revenue | 161.21M | 164.98M | 168.25M | 171.24M | 176.69M |
| Gross Profit | 693.29M | 697.00M | 706.87M | 729.21M | 744.32M |
| SG&A Expenses | 626.97M | 614.66M | 622.53M | 638.31M | 651.25M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 788.18M | 779.64M | 790.78M | 809.55M | 827.94M |
| Operating Income | 66.32M | 82.33M | 84.34M | 90.90M | 93.07M |
| Income Before Tax | 76.35M | 92.53M | 94.46M | 101.06M | 102.45M |
| Income Tax Expenses | 34.29M | 38.19M | 39.37M | 39.12M | 38.67M |
| Earnings from Continuing Operations | 42.06 | 54.34 | 55.08 | 61.94 | 63.79 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -30.00K | -- | -- | -- | -- |
| Net Income | 42.03M | 54.34M | 55.08M | 61.94M | 63.79M |
| EBIT | 66.32M | 82.33M | 84.34M | 90.90M | 93.07M |
| EBITDA | 80.86M | 95.79M | 97.49M | 103.46M | 105.77M |
| EPS Basic | 2.20 | 2.84 | 2.87 | 3.22 | 3.31 |
| Normalized Basic EPS | 2.49 | 3.02 | 3.08 | 3.28 | 3.32 |
| EPS Diluted | 2.18 | 2.83 | 2.86 | 3.21 | 3.30 |
| Normalized Diluted EPS | 2.49 | 3.01 | 3.06 | 3.27 | 3.31 |
| Average Basic Shares Outstanding | 76.43M | 76.58M | 76.75M | 76.99M | 77.10M |
| Average Diluted Shares Outstanding | 76.65M | 76.80M | 77.09M | 77.35M | 77.38M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |